Scarica l'app Stockscreener
85.15
1.33%
1.12
Pre-mercato:
85.24
0.09
+0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$84.03
Aprire:
$84.34
Volume 24 ore:
9.43M
Relative Volume:
0.70
Capitalizzazione di mercato:
$212.69B
Reddito:
$63.43B
Utile/perdita netta:
$16.42B
Rapporto P/E:
13.12
EPS:
6.49
Flusso di cassa netto:
$14.72B
1 W Prestazione:
+1.31%
1M Prestazione:
+6.40%
6M Prestazione:
-10.11%
1 anno Prestazione:
-25.77%
Intervallo 1D:
$84.00
$85.55
Intervallo di 1 settimana:
$82.82
$85.55
Portata 52W:
$73.31
$119.38
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
85.15 | 209.89B | 63.43B | 16.42B | 14.72B | 6.49 |
|
LLY
Lilly Eli Co
|
756.28 | 676.48B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.50 | 423.36B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
220.22 | 373.87B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
127.70 | 244.98B | 53.40B | 13.68B | 16.89B | 6.9231 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
16,034 Shares in Merck & Co., Inc. $MRK Purchased by Teza Capital Management LLC - MarketBeat
UniSuper Management Pty Ltd Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Clark Capital Management Group Inc. Has $1.98 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by New England Asset Management Inc. - MarketBeat
Britain defends investment record as Merck scraps labs over pharma environment - MarketScreener
Merck & Co., (MRK) and Daiichi Sankyo Announces Positive Results for Ifinatamab deruxtecan - MSN
Merck & Co. Withdrawal Seen As Warning Of UK’s Declining Attractiveness - insights.citeline.com
Ex-Dividend Reminder: Gilead Sciences, Thermo Fisher Scientific and Merck - Nasdaq
Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock? - Yahoo Finance
CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Chil - PharmiWeb.com
Merck's pneumococcal shot shows promise in at-risk children and teens - Reuters
Merck scraps £1 billion London research hub, citing U.K. investment issues By Investing.com - Investing.com
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees - BioSpace
Merck’s move to axe £1bn UK expansion was ‘commercial decision’, says minister - uk.finance.yahoo.com
Merck's pneumococcal shot shows promise in children and teens in study - Reuters
Woodline Partners LP Has $68.62 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Scraps Plans for £1 Billion London Hub in Fresh Blow to UK - Bloomberg.com
Merck says trial data for pneumonia shot Capvaxive shows promise in younger people - Seeking Alpha
Legacy Advisory Services LLC Invests $403,000 in Merck & Co., Inc. $MRK - MarketBeat
Merck's pneumococcal shot shows promise in late-stage study - MarketScreener
Nearwater Capital Markets Ltd Purchases New Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Signature Estate & Investment Advisors LLC - MarketBeat
Merck axes £1B London lab, calls UK 'uninvestable', threatening 125 jobs - International Business Times UK
Scientech Research LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Jacobs Levy Equity Management Inc. Sells 34,822 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50 - Stocktwits
Merck scraps £1bn London expansion as report warns UK drugs sector ‘losing out’ - uk.finance.yahoo.com
Merck & Co., Inc. $MRK Holdings Trimmed by Nippon Life Global Investors Americas Inc. - MarketBeat
SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? - Stocktwits
Merck to scrap London drug research centre - Reuters
Merck Pulls The Plug On London Research Center - Finimize
Merck manager’s awkward whispers didn’t constitute harassment, judge rules - HR Dive
US pharma giant Merck ditches plan for $1.4-bn research centre in UK - Citizen Tribune
Gotham Asset Management LLC Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck to cancel London drug research center, lay off scientists : FT - MSN
Helping protect against vaccine-preventable diseases - Merck.com
Merck halts U.K. research operations and bails on new facility in London - statnews.com
Merck closes £1B London research hub - breakingthenews.net
Merck plans to discontinue discovery research operations in UK - MarketScreener
Merck to scrap $1.35 billion London drug research centre, FT reports - MarketScreener
Merck scraps 1 billion pounds London drug research centre in blow to UK growthFT - MarketScreener
Merck slams UK as it scraps £1bn London drug research centre - Financial Times
31,963 Shares in Merck & Co., Inc. $MRK Bought by Caxton Associates LLP - MarketBeat
Ascent Group LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Great Lakes Advisors LLC Buys 13,648 Shares of Merck & Co., Inc. $MRK - MarketBeat
RNC Capital Management LLC Has $35.34 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Voleon Capital Management LP Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Jones Financial Companies Lllp - MarketBeat
Ashton Thomas Private Wealth LLC Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Closes $6 Billion Notes Offering - TipRanks
Merck Avoids Liability for Supervisor Whispering in Worker’s Ear - Bloomberg Law News
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):